Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis
Editorial Group: Cochrane Musculoskeletal Group
Published Online: 27 APR 1998
Assessed as up-to-date: 9 SEP 2007
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Pope J, Fenlon D, Thompson A, Shea B, Furst D, Wells GA, Silman A. Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis. Cochrane Database of Systematic Reviews 1998, Issue 2. Art. No.: CD000954. DOI: 10.1002/14651858.CD000954.
- Publication Status: Edited (no change to conclusions)
- Published Online: 27 APR 1998
This article has been cited by:
- 15-HT2a receptor antagonism reduces burn-induced macromolecular efflux in rats, European Journal of Trauma and Emergency Surgery, 2015,, , , , ,